Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire

Autor: Lukas Stastny, Mauro Romano, Flavio Ribichini, Jana Kurucova, Jorge Salgado-Fernandez, Martin Thoenes, Cornelia Deutsch, Bruno García del Blanco, Dominique Himbert, Pierluigi Stefàno, Marina Urena-Alcazar, Derk Frank, Carlo Di Mario, Simon Kennon, Nikolaos Bonaros, Thierry Lefèvre, Jose Joaquin Cuenca Castillo, Peter Bramlage, Rima Styra, Lenka Sykorova, Claudia M. Lüske
Přispěvatelé: Institut Català de la Salut, [Frank D] Department of Internal Medicine III (Cardiology, Angiology and Critical Care), UKSH University Clinical Center Schleswig‐Holstein, and DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Arnold‐Heller Strasse 3, Kiel, 24105, Germany. [Kennon S] Department of Cardiology, Barts Heart Centre, St. Bartholomew’s Hospital, London, UK. [Bonaros N, Stastny L] Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria. [Romano M, Lefèvre T] Department of Thoracic and Cardiovascular Surgery, Department of Interventional Cardiology, Hôpital Privé Jacques Cartier, Massy, France. [Garcia Del Blanco B] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER CV, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Aortic valve
Quality of life
lcsh:Diseases of the circulatory (Cardiovascular) system
Chronic condition
medicine.medical_specialty
Canada
Intraclass correlation
medicine.medical_treatment
Pacients - Satisfacció
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Aortic valve replacement
Valve replacement
Surveys and Questionnaires
Original Research Articles
medicine
Humans
030212 general & internal medicine
Prospective Studies
Original Research Article
Prospective cohort study
Cardiovascular Diseases::Heart Diseases::Heart Valve Diseases::Aortic Valve Stenosis [DISEASES]
ambiente y salud pública::salud pública::medidas epidemiológicas::demografía::estado de salud::calidad de vida [ATENCIÓN DE SALUD]
Pròtesis valvulars cardíaques
business.industry
Questionnaire
Aortic stenosis
intervenciones quirúrgicas::procedimientos quirúrgicos cardiovasculares::procedimientos quirúrgicos cardíacos::implantación de prótesis valvulares cardíacas::sustitución valvular aórtica con catéter [TÉCNICAS Y EQUIPOS ANALÍTICOS
DIAGNÓSTICOS Y TERAPÉUTICOS]

Reproducibility of Results
Aortic Valve Stenosis
medicine.disease
Europe
Stenosis
Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Health Status::Quality of Life [HEALTH CARE]
enfermedades cardiovasculares::enfermedades cardíacas::enfermedades de las válvulas cardíacas::estenosis de la válvula aórtica [ENFERMEDADES]
medicine.anatomical_structure
Treatment Outcome
lcsh:RC666-701
Aortic Valve
Physical therapy
Vàlvula aòrtica - Estenosi
Surgical Procedures
Operative::Cardiovascular Surgical Procedures::Cardiac Surgical Procedures::Heart Valve Prosthesis Implantation::Transcatheter Aortic Valve Replacement [ANALYTICAL
DIAGNOSTIC AND THERAPEUTIC TECHNIQUES
AND EQUIPMENT]

Cardiology and Cardiovascular Medicine
business
Zdroj: Scientia
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 1, Pp 270-279 (2021)
Popis: Reemplaçament de la vàlvula aòrtica; Qualitat de vida; Qüestionari Reemplazo de la válvula aórtica; Calidad de vida; Cuestionario Aortic valve replacement; Quality of life; Questionnaire Aims There is no quality of life tool specifically developed for patients with severe aortic stenosis (AS) to assess how this chronic condition and its treatment affect patients. The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) has been developed to overcome this gap. The results of the validation of the TASQ in patients undergoing treatment for severe AS are presented. Methods and results Prospective study at 10 centres in Europe and Canada, which enrolled 274 patients with severe symptomatic AS undergoing surgical or transcatheter aortic valve replacement. Mean TASQ score at baseline was 71.2 points and increased to 88.9 three months after aortic valve implantation (P < 0.001). Increases were seen for the emotional impact (32.0 to 39.0; P < 0.001), physical limitations (14.8 to 22.0; P < 0.001), and physical symptoms (8.5 vs. 11.0; P < 0.001) domains. Internal consistency was good/excellent for overall TASQ score (α = 0.891) and for the physical limitation, emotional impact, and social limitation domains (α = 0.815–0.950). Test–retest reliability was excellent or strong for the overall TASQ (intraclass correlation coefficient of 0.883) and for the physical symptoms, physical limitation, emotional impact, and social limitation domains (intraclass correlation coefficient of 0.791–0.895). Responsiveness was medium overall (Cohen's d = 0.637) and medium/large for physical symptoms, emotional impact, and physical limitations (0.661–0.812). Sensitivity to change was significant for physical symptoms, physical limitations (both P < 0.001), emotional impact (P = 0.003), and social limitations (P = 0.038). Conclusions The TASQ is a new, brief, self‐administered, and clinically relevant health‐specific tool to measure changes in quality of life in patients with AS undergoing an intervention. This work was supported by a research grant provided by Edwards Lifesciences (Nyon, Switzerland) to the Institute for Pharmacology and Preventive Medicine (Cloppenburg, Germany).
Databáze: OpenAIRE